Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04648254 |
| Title | Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Qurient Co., Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Southern California | RECRUITING | Los Angeles | California | 90033 | United States | Details |
| Cedars-Sinai Medical Center | RECRUITING | Los Angeles | California | 90048 | United States | Details |
| Northwestern University | RECRUITING | Chicago | Illinois | 60611 | United States | Details |
| Atlantic Health System Hospital | RECRUITING | Morristown | New Jersey | 07960 | United States | Details |